Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Reddin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Placenta|June 13, 2024
Gastroschisis associated changes in the placental transcriptomeMaaike Jongen, Ian Reddin, Sharon Cave, et al.
Scientific Reports|December 1, 2022
Value of p53 sequencing in the prognostication of head and neck cancer: a systematic review and meta-analysisShadi Basyuni, Gareth Nugent, Ashley Ferro, et al.
Cancers|May 3, 2020
YM155-Adapted Cancer Cell Lines Reveal Drug-Induced Heterogeneity and Enable the Identification of Biomarker Candidates for the Acquired Resistance SettingMartin Michaelis, Mark N Wass, Ian Reddin, et al.
Clinical Epigenetics|October 20, 2023
Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cellsEleanor O'Brien, Carmen Tse, Ian Tracy, et al.
British Journal of Cancer|July 10, 2025
Cancer-associated fibroblasts are associated with neo-adjuvant treatment response in oesophageal adenocarcinomaRobert C Walker, Stella P Breininger, Benjamin P Sharpe, et al.
The EMBO Journal|November 15, 2024
Differentiation signals induce APOBEC3A expression via GRHL3 in squamous epithelia and squamous cell carcinomaNicola J Smith, Ian Reddin, Paige Policelli, et al.
Research Square|March 18, 2024
Differentiation signals induce <i>APOBEC3A</i> expression via GRHL3 in squamous epithelia and squamous cell carcinomaNicola J Smith, Ian Reddin, Paige Policelli, et al.
Nature Communications|October 7, 2022
Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significanceAnkur Chakravarthy, Ian Reddin, Stephen Henderson, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Placenta|June 13, 2024
Gastroschisis associated changes in the placental transcriptomeMaaike Jongen, Ian Reddin, Sharon Cave, et al.
Scientific Reports|December 1, 2022
Value of p53 sequencing in the prognostication of head and neck cancer: a systematic review and meta-analysisShadi Basyuni, Gareth Nugent, Ashley Ferro, et al.
Cancers|May 3, 2020
YM155-Adapted Cancer Cell Lines Reveal Drug-Induced Heterogeneity and Enable the Identification of Biomarker Candidates for the Acquired Resistance SettingMartin Michaelis, Mark N Wass, Ian Reddin, et al.
Clinical Epigenetics|October 20, 2023
Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cellsEleanor O'Brien, Carmen Tse, Ian Tracy, et al.
British Journal of Cancer|July 10, 2025
Cancer-associated fibroblasts are associated with neo-adjuvant treatment response in oesophageal adenocarcinomaRobert C Walker, Stella P Breininger, Benjamin P Sharpe, et al.
The EMBO Journal|November 15, 2024
Differentiation signals induce APOBEC3A expression via GRHL3 in squamous epithelia and squamous cell carcinomaNicola J Smith, Ian Reddin, Paige Policelli, et al.
Research Square|March 18, 2024
Differentiation signals induce <i>APOBEC3A</i> expression via GRHL3 in squamous epithelia and squamous cell carcinomaNicola J Smith, Ian Reddin, Paige Policelli, et al.
Nature Communications|October 7, 2022
Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significanceAnkur Chakravarthy, Ian Reddin, Stephen Henderson, et al.
Pageof 1